Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hlc.2020.04.006 http://scihub22266oqcxt.onion/10.1016/j.hlc.2020.04.006 32418874!7192105!32418874     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32418874&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Heart+Lung+Circ 2020 ; 29 (7): e85-e87 Nephropedia Template TP {{tp|p=32418874|t=2020. Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement |pdf=|usr=}}{{32418874}} gab.com Text Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement JO: Heart Lung Circ http://www.kidney.de/pget.php?&tw=1&pmid=32418874 #FOAvip In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care. Twit Text FOAVip Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement ????Heart Lung Circ http://www.kidney.de/pget.php?&tw=1&pmid=32418874 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32418874 #FOAvip English Wikipedia <ref>{{Cite pmid|32418874}}</ref> Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement #MMPMID32418874 Gray B; Semsarian C; Fatkin D; Ingles J; Atherton JJ; Davis AM; Sanders P; Pachter N; Skinner JR; Stiles MK Heart Lung Circ 2020[Jul]; 29 (7): e85-e87 PMID32418874show ga In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care. |*Cardiac Conduction System Disease/congenital/epidemiology/therapy[MESH] |*Cardiology/methods/organization & administration/trends[MESH] |*Communicable Disease Control/methods/organization & administration[MESH] |*Coronavirus Infections/epidemiology/prevention & control[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/epidemiology/prevention & control[MESH] |Adult[MESH] |Australia/epidemiology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Child[MESH] |Consensus[MESH] |Humans[MESH] |New Zealand/epidemiology[MESH] |Patient Care Management/*methods[MESH] |SARS-CoV-2[MESH]Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of(epmc).pdf DeepDyve Pubget Overpricing